Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:affects |
both genders
|
| gptkbp:age_group |
all ages
|
| gptkbp:associated_with |
toxic epidermal necrolysis
|
| gptkbp:can_lead_to |
hospitalization
long-term follow-up intensive care unit admission |
| gptkbp:caused_by |
medications
infections |
| gptkbp:characterized_by |
systemic symptoms
detachment of the epidermis extensive necrosis |
| gptkbp:complication |
gptkb:disease
vision problems permanent skin damage |
| gptkbp:diagnosis |
clinical evaluation
varies by severity skin biopsy |
| gptkbp:epidemiology |
incidence is low
rare condition more common in certain populations |
| gptkbp:first_described_by |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
stevens-johnson syndrome
|
| gptkbp:is_common_in |
gptkb:children
young adults older adults |
| gptkbp:prevention |
avoidance of known triggers
|
| gptkbp:public_awareness |
educational campaigns ongoing
increased awareness needed support groups available |
| gptkbp:related_to |
gptkb:drug-induced_hypersensitivity_syndrome
autoimmune diseases viral infections bacterial infections |
| gptkbp:research_focus |
genetic factors
prevention strategies treatment options underlying mechanisms |
| gptkbp:risk_factor |
genetic predisposition
HIV infection previous drug reactions |
| gptkbp:symptoms |
blistering
skin rash mucous membrane involvement |
| gptkbp:treatment |
supportive care
corticosteroids discontinuation of offending drug |
| gptkbp:bfsParent |
gptkb:carbamazepine
|
| gptkbp:bfsLayer |
5
|